12 Photos and videos
John Spertus retweeted
14 Nov 2021
Congrats to the #CHIEF_HF investigators…digital first trial, with drug, & for regulatory indication expansion. Canagliflozin improved quality of life in patients with heart failure. But the trial design even bigger news. Heralds new era in trial implementation. @jspertus #AHA21
1
4
28
6 Mar 2021
So excited to see the field move from using PROs as descriptive outcomes to a means of improving the patient-centeredness of care. @VHejjaji @MichaelNassifMD @djc795 @gcfmd @GreggWStone @CircOutcomes @hmkyale tctmd.com/news/beyond-resear…
1
6
36
John Spertus retweeted
17 May 2020
Thank you Michael Ho program chair of #QCOR20 & @bnallamo EIC of @CircOutcomes for a fantastic virtual @AHAMeetings & to all on planning committee @UmeshKhotMD @rashmeeushah & all expert faculty @TYWangMD @leftbundle @DrKLindley @ericpetersonMD @jspertus @kejoynt @jasonwasfy
16 May 2020
Thank you for joining us at #QCOR20! Miss a session? Access through QCOR OnDemand for the next 90 days! Visit us in the #HeartHub year-round for curated content from AHA Journals and Science News, membership resources & Early Career content. hearthubs.org/qcor
1
10
24
John Spertus retweeted
The second is from ISCHEMIA-CKD and noted that nearly half of patients had no angina in the prior month. Even in patients with angina, the health status benefit with revascularization was transient and less significant than in the primary ISCHEMIA trial.
1
4
10
21 Mar 2020
Amazing email today for those on satellite internet from @ViasatInternet @ViasatInc. In a world where we have to work at home, no break on costs or fees for more access. I used mine up in a week and now on dial-up speed. Just criminal. #makingmoneyfromCovid
5
20 Mar 2020
#COVID19 Very concerned about unfounded recommendations to stop ACEI/ARBs in patients with heart disease. Agree with @ACCinTouch and @AHAScience that patients need to consider these decisions in close consultation with their doctor. @UMKC @MidAmericaHeart
3
24
28 Feb 2020
Fabulous cutting edge initiative to understand the roles of new technology to improve human health. Thrilled to be part of this ground-breaking study with @CMichealGibson...
25 Feb 2020
#JNJ, in collaboration with Apple, has launched the Heartline™ Study—a virtual research study using wearable technology & cutting-edge apps to help detect #AFib. Learn about the study & its potential to impact the up to 6 million in the U.S. with AFib: bit.ly/32ryxNA
12
38
5 Jan 2020
So the week of Thanksgiving, the NEJM publishes a study on the benefits of intermittent fasting. On New Year’s they publish a study showing that alcohol abstinence reduces Afib. What are they going to publish on Valentine’s day?? ... Ponderings with @MichaelNassifMD @hmkyale
11
26
156
2 Nov 2019
Looking forward to discussing #JACC paper about personalizing the decision for PCI vs. CABQ in patients with diabetes and multi-vessel disease.
2 Nov 2019
#ACCIC #HeartTalk
Countdown ⏳T-5 minutes
@MohammedQintar @jspertus @djc795 @adityadoc1
Join us ⤵️⤵️⤵️⤵️
1
16
John Spertus retweeted
13 Jun 2019
In a new #MethodsPaper, authors demonstrate how to integrate survival and health status outcomes in a RCT using a joint Bayesian framework #AHAJournals | ow.ly/Nlhp50uD5bi
6
9
14 Dec 2018
I applaud UC for drawing attention to this. The quest for profits by Elsevier is impairing the sharing of science, which is our primary goal as researchers and scientists.
14 Dec 2018
"Consider declining to review for Elsevier journals"
Notice to All Faculty by Executive Vice Chancellor and Provost of University of California @UCsystem. Unprecedented!
See chronicle.com/article/In-Tal… for more.
#openaccess #bigdeals
7
23 Nov 2018
Great to see real-world evidence of the QoL benefit of mitraclip. Glad to see our outcomes focus on how patients are feeling and functioning. @MidAmericaHeart @djc795 @akcmahi
23 Nov 2018
Our study from ACC/STS TVT on quality of life after edge-to-edge transcatheter mitral valve repair ja.ma/2PLkJdE in real-world (mostly degenerative MR). Will be interesting to see the QOL results of COAPT.
5
21
16 Nov 2018
So great to see our fellows leveraging their analytic skills to address practical clinical questions and help guide how best to manage patients.
@krishnapatel888 discussing increase hazard of death in patients with MBFR<2 in @MidAmericaHeart PET database. Cut point for improvement with revascularization at MBFR levels <1.8
11
11 Nov 2018
Improving the future of care for pregnant women with heart disease. The future starts tonight! @MidAmericaHeart @karenflorio2 @MinnowWalsh
3
6
24
6 Apr 2018
Watching @medtmaddox presenting vision for redesigning MI care to improve value at #QCOR18. Way to go!!
6
12
25 Feb 2018
Doctors, Revolt! nytimes.com/2018/02/24/opini… Great to periodically have our perspective recalibrated.
1
12